Do analysts rate NTHI or SXTPW?

Neonc Technologies currently has a consensus target price of $16.00, suggesting a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Neonc Technologies is more favorable than 60 Degrees Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 60 Degrees Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, NTHI or SXTPW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neonc Technologies $39.99K N/A N/A N/A N/A 60 Degrees Pharmaceuticals $1.11M N/A N/A N/A N/A

Is NTHI or SXTPW more profitable?

Company Net Margins Return on Equity Return on Assets Neonc Technologies N/A N/A N/A 60 Degrees Pharmaceuticals N/A N/A N/A

Does the media refer more to NTHI or SXTPW?

In the previous week, Neonc Technologies and Neonc Technologies both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Neonc Technologies' score of 0.57 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neonc Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 60 Degrees Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate BFRIW or NTHI?

Neonc Technologies has a consensus target price of $16.00, suggesting a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Biofrontera. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biofrontera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better valuation and earnings, BFRIW or NTHI?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $46.18M N/A N/A N/A N/A Neonc Technologies $39.99K N/A N/A N/A N/A

Is BFRIW or NTHI more profitable?

Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A Neonc Technologies N/A N/A N/A

Do analysts rate CINGW or NTHI?

Neonc Technologies has a consensus price target of $16.00, indicating a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Cingulate. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cingulate 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has preferable valuation and earnings, CINGW or NTHI?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cingulate N/A N/A N/A N/A N/A Neonc Technologies $39.99K N/A N/A N/A N/A

Is CINGW or NTHI more profitable?

Company Net Margins Return on Equity Return on Assets Cingulate N/A N/A N/A Neonc Technologies N/A N/A N/A

Do analysts recommend CLVR or NTHI?

Neonc Technologies has a consensus price target of $16.00, indicating a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Clever Leaves. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clever Leaves 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better valuation and earnings, CLVR or NTHI?

Neonc Technologies has lower revenue, but higher earnings than Clever Leaves. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clever Leaves $17.42M 0.00 -$17.90M -$9.66 N/A Neonc Technologies $39.99K N/A N/A N/A N/A

Is CLVR or NTHI more profitable?

Company Net Margins Return on Equity Return on Assets Clever Leaves N/A N/A N/A Neonc Technologies N/A N/A N/A

Do analysts prefer CMRAW or NTHI?

Neonc Technologies has a consensus target price of $16.00, suggesting a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Comera Life Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Comera Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better earnings and valuation, CMRAW or NTHI?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Comera Life Sciences $1.00M N/A N/A N/A N/A Neonc Technologies $39.99K N/A N/A N/A N/A

Is CMRAW or NTHI more profitable?

Company Net Margins Return on Equity Return on Assets Comera Life Sciences N/A N/A N/A Neonc Technologies N/A N/A N/A

Neonc Technologies (NTHI) Competitors

$5.12 +0.33 (+6.78%)

As of 12:36 PM Eastern

Compare

NTHI vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Neonc Technologies stock or one of its competitors? Neonc Technologies's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Neonc Technologies compare to 60 Degrees Pharmaceuticals?

Neonc Technologies (NASDAQ:NTHI) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A
60 Degrees Pharmaceuticals	$1.11M	N/A	N/A	N/A	N/A

In the previous week, Neonc Technologies and Neonc Technologies both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Neonc Technologies' score of 0.57 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neonc Technologies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
60 Degrees Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
Neonc Technologies	N/A	N/A	N/A
60 Degrees Pharmaceuticals	N/A	N/A	N/A

Neonc Technologies currently has a consensus target price of $16.00, suggesting a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Neonc Technologies is more favorable than 60 Degrees Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
60 Degrees Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Neonc Technologies beats 60 Degrees Pharmaceuticals on 3 of the 5 factors compared between the two stocks.

How does Neonc Technologies compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Neonc Technologies (NASDAQ:NTHI) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Neonc Technologies has a consensus target price of $16.00, suggesting a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Biofrontera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biofrontera	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$46.18M	N/A	N/A	N/A	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

In the previous week, Neonc Technologies had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Neonc Technologies and 0 mentions for Biofrontera. Neonc Technologies' average media sentiment score of 0.57 beat Biofrontera's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Biofrontera	Neutral
Neonc Technologies	Positive

Summary

Neonc Technologies beats Biofrontera on 5 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Neonc Technologies (NASDAQ:NTHI) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Neonc Technologies had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for Neonc Technologies and 0 mentions for Cingulate. Neonc Technologies' average media sentiment score of 0.57 beat Cingulate's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Cingulate	Neutral
Neonc Technologies	Positive

Company	Net Margins	Return on Equity	Return on Assets
Cingulate	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Neonc Technologies has a consensus price target of $16.00, indicating a potential upside of 212.81%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Cingulate.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cingulate	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cingulate	N/A	N/A	N/A	N/A	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

Summary

Neonc Technologies beats Cingulate on 6 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Neonc Technologies (NASDAQ:NTHI) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clever Leaves	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Company	Net Margins	Return on Equity	Return on Assets
Clever Leaves	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Neonc Technologies has lower revenue, but higher earnings than Clever Leaves.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clever Leaves	$17.42M	0.00	-$17.90M	-$9.66	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

In the previous week, Neonc Technologies had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for Neonc Technologies and 0 mentions for Clever Leaves. Neonc Technologies' average media sentiment score of 0.57 beat Clever Leaves' score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Clever Leaves	Neutral
Neonc Technologies	Positive

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Neonc Technologies beats Clever Leaves on 5 of the 8 factors compared between the two stocks.

How does Neonc Technologies compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and Neonc Technologies (NASDAQ:NTHI) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Comera Life Sciences	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Comera Life Sciences	$1.00M	N/A	N/A	N/A	N/A
Neonc Technologies	$39.99K	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Comera Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Neonc Technologies had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Neonc Technologies and 0 mentions for Comera Life Sciences. Neonc Technologies' average media sentiment score of 0.57 beat Comera Life Sciences' score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Comera Life Sciences	Neutral
Neonc Technologies	Positive

Summary

Neonc Technologies beats Comera Life Sciences on 5 of the 6 factors compared between the two stocks.

Get Neonc Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTHI vs. The Competition

Export

Metric	Neonc Technologies	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$12.18B	$7.20B	$12.86B
Dividend Yield	N/A	2.59%	2.53%	8.57%
P/E Ratio	N/A	787.20	272.93	25.37
Price / Sales	N/A	759.68	617.69	98.61
Price / Cash	N/A	94.80	77.82	52.27
Price / Book	N/A	12.40	12.86	6.16
Net Income	N/A	$2.82B	$3.47B	$349.63M
7 Day Performance	9.06%	3.87%	1.01%	-0.16%
1 Month Performance	49.13%	6.79%	5.69%	0.73%
1 Year Performance	-31.53%	10.53%	25.55%	15.35%

Neonc Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTHI Neonc Technologies	3.8275 of 5 stars	$5.12 +6.8%	$16.00 +212.8%	-33.5%	$0.00	$39.99K	N/A	8
SXTPW 60 Degrees Pharmaceuticals	N/A	$0.04 -5.3%	N/A	-62.0%	$0.00	$1.11M	N/A	2	News Coverage Positive News
BFRIW Biofrontera	N/A	$0.03 -8.8%	N/A	-83.7%	$0.00	$46.18M	N/A	70	Positive News Gap Up
CINGW Cingulate	N/A	$0.01 -23.1%	N/A	-84.3%	$0.00	N/A	N/A	20	Gap Up
CLVR Clever Leaves	N/A	$0.00 flat	N/A	N/A	$0.00	$17.42M	N/A	560

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTHI) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Neonc Technologies (NTHI) Competitors

NTHI vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

How does Neonc Technologies compare to 60 Degrees Pharmaceuticals?

Summary

How does Neonc Technologies compare to Biofrontera?

Summary

How does Neonc Technologies compare to Cingulate?

Summary

How does Neonc Technologies compare to Clever Leaves?

Summary

How does Neonc Technologies compare to Comera Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTHI vs. The Competition

Neonc Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Neonc Technologies (NTHI) Competitors

NTHI vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

How does Neonc Technologies compare to 60 Degrees Pharmaceuticals?

Which has stronger earnings and valuation, NTHI or SXTPW?

Does the media refer more to NTHI or SXTPW?

Is NTHI or SXTPW more profitable?

Do analysts rate NTHI or SXTPW?

Summary

How does Neonc Technologies compare to Biofrontera?

Is BFRIW or NTHI more profitable?

Do analysts rate BFRIW or NTHI?

Which has better valuation and earnings, BFRIW or NTHI?

Does the media refer more to BFRIW or NTHI?

Summary

How does Neonc Technologies compare to Cingulate?

Does the media prefer CINGW or NTHI?

Is CINGW or NTHI more profitable?

Do analysts rate CINGW or NTHI?

Which has preferable valuation and earnings, CINGW or NTHI?

Summary

How does Neonc Technologies compare to Clever Leaves?

Do analysts recommend CLVR or NTHI?

Is CLVR or NTHI more profitable?

Which has better valuation and earnings, CLVR or NTHI?

Does the media prefer CLVR or NTHI?

Do insiders & institutionals hold more shares of CLVR or NTHI?

Summary

How does Neonc Technologies compare to Comera Life Sciences?

Is CMRAW or NTHI more profitable?

Which has better earnings and valuation, CMRAW or NTHI?

Do analysts prefer CMRAW or NTHI?

Does the media refer more to CMRAW or NTHI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTHI vs. The Competition

Neonc Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools